Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-25 @ 7:36 PM
Study NCT ID:
NCT00698932
Status:
COMPLETED
Last Update Posted:
2011-09-21
First Post:
2008-06-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1680C00005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Peter Öhman, MD, PhD, Medical Science Director
Old Organization:
AstraZeneca Pharmaceuticals
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |